Compare companies
Sector
Report publication year
This is a small selection of the indicators assessed within the Framework. Use the drop-down options above to focus on a particular sector or publication year. Click on the company name to view the individual dashboard, or for a comprehensive insight download the latest full dataset. Presence of a dash (–) indicates there is no data related to this metric. Additional companies and financial years will be added as assessments become available.
| Name | Living wage accredited | Tax reporting (GRI 207) | Remuneration committee discretion (direction) | Director from workforce | Trade union relations (disclosure) | Worker consultation on top pay (disclosure) | 80%+ shareholder support on pay | CEO total pay (GBP) | CEO total pay change | CEO pay ratio (to median employee) | Gender pay (women % in top quartile) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AstraZeneca plc |  |
 |
— | |
|
|
|
16,853,000 | 9.98% | 182:1 | 42.70% |
| ConvaTec Group plc | |
|
— | |
|
|
|
4,264,000 | -1.77% | 80:1 | 44.00% |
| GSK plc | |
|
— | |
|
|
|
12,718,000 | 50.46% | 152:1 | 47.11% |
| Haleon plc | |
|
— | |
|
|
|
5,763,000 | 145.23% | 50:1 | 44% |
| Hikma Pharmaceuticals plc | |
|
 |
|
|
|
|
1,217,908 | -73.62% | — | — |
| Smith & Nephew plc | |
|
— | |
|
|
|
3,654,391 | -32.57% | 72:1 | 38% |